STOCK TITAN

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NeuroPace (Nasdaq: NPCE), a medical device company specializing in epilepsy treatment solutions, has announced its participation in the upcoming Leerink Partners 2025 Global Healthcare Conference. The company's management team is scheduled to present on Monday, March 10, 2025, at 4:20pm ET (1:20pm PT) in Miami, FL.

The presentation will be available through a live webcast, with a replay accessible for two weeks afterward through the Events section of NeuroPace's Investor website. Additionally, the management team will be conducting investor meetings throughout the conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.93% News Effect

On the day this news was published, NPCE gained 0.93%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerink Partners 2025 Global Healthcare Conference at 4:20pm ET (1:20pm PT) on Monday, March 10, 2025, in Miami, FL. Management will also host investor meetings during the conference.

The presentation will be accessible via live webcast here. A webcast replay will be available for two weeks following the presentation in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com.

About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com


FAQ

When is NeuroPace (NPCE) presenting at the Leerink Partners Healthcare Conference 2025?

NeuroPace will present on Monday, March 10, 2025, at 4:20pm ET (1:20pm PT) in Miami, FL.

How can investors watch NeuroPace's (NPCE) Leerink Conference presentation?

The presentation will be available via live webcast, with a replay accessible for two weeks on NeuroPace's Investor website.

Will NeuroPace (NPCE) management be available for investor meetings at the Leerink Conference?

Yes, management will host investor meetings during the conference.

How long will the replay of NeuroPace's (NPCE) Leerink presentation be available?

The webcast replay will be available for two weeks following the presentation.
Neuropace Inc

NASDAQ:NPCE

NPCE Rankings

NPCE Latest News

NPCE Latest SEC Filings

NPCE Stock Data

520.27M
25.37M
2.71%
82.04%
3.04%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MOUNTAIN VIEW